PARIS (AFP) - One tiny brain cell is all it takes to restore voluntary movement of paralysed muscles, scientists in the United States reported Wednesday. More »
PARIS (AFP) - The arthritis drug Vioxx nearly doubled the risk of heart attack and stroke compared to no treatment at all, according to a long-term follow-up study released Tuesday. More »
LONDON/ZURICH (Reuters) - Investors seeking shelter from the financial storm may be reassured about the defensive qualities of pharmaceuticals when the world's top drug manufacturers report third-quarter results from next week. More »
LOS ANGELES (Reuters) - San Diego's Scripps Translational Science Institute said on Thursday it will conduct the first study to assess whether people undergoing genetic testing ultimately change their behaviour. More »
STOCKHOLM (Reuters) - Two Americans and a Japanese researcher won the 2008 Nobel Prize in Chemistry Wednesday for the discovery of a glowing jellyfish protein that makes cells, tissues and even organs light up -- a tool used by thousands of researchers around the world. More »
PARIS (AFP) - Scientists on Wednesday said they had cracked the genetic codes of a major malaria parasite and a monkey parasite also suspected of spreading the disease, an achievement adding to the sequencing six years ago of Plasmodium falciparum, the greatest malarial threat. More »
LONDON (Reuters) - Scientists have discovered a gene mutation linked to the most common cause of blindness in the developed world, holding out the prospect of better treatments and perhaps eventually a cure. More »
BOSTON (Reuters) - ImClone Systems has agreed to be acquired by Eli Lilly for about $6.1 billion (3.5 billion pounds) after rebuffing a sweetened takeover offer from Bristol-Myers Squibb , sources familiar with the situation said on Monday. More »
CHICAGO (Reuters) - Reptiles, monkeys, rodents and other exotic pets are growing in popularity but should be discouraged in homes with small children or people with immune system problems, according to a report published on Monday. More »
LONDON (Reuters) - GlaxoSmithKline has agreed to settle a long-standing U.S. case over its antidepressant Paxil by paying insurers $40 million (22.6 million pounds) to reimburse health plans that paid for children and adolescents to receive the drug. More »

In this June 5, 2008 file photo, chickens look out of their pen in a downtown neighborhood …
Editor's Corner
Copyright © 2008 Yahoo! All rights reserved.
Notice: We collect personal information on this site. To learn more about how we use your information, see our: Privacy Policy